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Despite great research advances in neuroscience in the past few decades, the tasks of unraveling the etiopathogeny of psychiatric and neurological disorders, and developing treatments truly capable of interfering with the pathological processes underlying the symptoms of these disorders, remain both highly challenging.
In order to foster top-level translational studies to face the above challenges, many research centers around the world have invested on strengthening interdisciplinary collaborations, combining the expertise of different, well-established laboratories. 1, 2 Such collaborations allow the organization of multicentric, longitudinal studies with neuropsychiatric disorders. In addition, the use of animal models and other basic neuroscience methods allows the detailing of the molecular processes underlying the symptoms of these neuropsychiatric disorders and the clinical response of patients to the existing treatments. With that strategy, the integration between clinical research and experimental therapeutic targets and novel pharmacological agents for the treatment of neuropsychiatric disorders.
Universidade de São Paulo (PRP-USP) selected proposals for the creation of new Centers for Research Support, aimed at bringing together specialists from one or more institutes of USP to work on convergent interdisciplinary research programs. Taking into account the neuroscience challenges outlined above, a group of more than 40 academics with well-established lines of investigation proposed the creation of a Center for Research Support on Applied Neuroscience (NAPNA-USP). This group, liasing psychiatrists, neurologists, radiologists, basic scientists, pharmacologists, epidemiologists, psychologists, engineers and computer scientists from 10 different institutes and schools of USP, proposed a research investigating a wide range of neuropsychiatric disorders. In order to accomplish that, we plan to facilitate access to the full range of equipment and human expertise of each of the research groups at USP, in a multilateral fashion. This aims to bring more uniformity to the methods of acquisition and processing of clinical and biological data across the participating institutes, with the ultimate purpose of creating a large data repository for shared use. We plan to prioritize the investigation of biomarkers that may be used in the future to inform diagnoses of neuropsychiatric disorders and to predict outcome in clinical practice, in an interdisciplinary fashion. In tandem with those clinical studies, we propose to carry out experiments using neuronal cultures and animal models in vivo, in order to validate the biomarkers investigated in humans and to carry out preclinical tests of novel therapeutic interventions.
For more than a year, the communication of the teams of NAPNA-USP has progressively increased, taking the form of a virtual institute of neuroscience (www.napnausp.org.br). We have also organized meetings to be carried out twice every year, and several novel interdisciplinary lines of investigation are now being started. Some of these novel research organized by members of NAPNA-USP following the request by RBP Psychiatry. was prepared by basic neuroscientists, nuclear medicine physicians and psychiatrists from USP. It addresses novel functional neuroimaging applications based on PET and SPECT methods, illustrating how such well-established diagnostic techniques have recently moved forward taking advantage the new radiotracers discussed in this review have been developed to map brain molecular mechanisms that have been studies using sophisticated animal models. Such newly discovered molecular mechanisms are now established as critical to the pathophysiology of neurodegenerative disorders such as Alzheimer's disease and Parkinsons disease.
The same reasoning applies to the meta-analysis presented by Maia-de-Oliveira et al. The knowledge advances about intracellular mechanisms underlying synaptic neurotransmission, which emerged from studies of basic neuroscience over the past few years, have led psychiatrists to revise concepts and to engender more complex neurochemical models than the traditional theories that propose, quite simplistically, the emergence of mental symptoms. The authors highlight the limitations of theories that propose changes in dopaminergic system as the central pathophysiological basis for the symptoms of schizophrenia, and conversely discuss several recent studies that give support to nitric oxide as one other key element in the neurobiology of schizophrenia. Their aroxide over processes of intracellular activation of secondmessenger systems, as well as the regulation of glutamate al.) reviews recent evidence indicating that the endocannabinoid system is critically involved in the etiopathogeny of schizophrenia. It should be noted that this article was produced by neuroscientists from other Brazilian academic institutions that collaborate with groups from NAPNA. This in helping to organize a wider research network involving other leading groups of Brazilian neuroscience.
The following article, by Torrão et al., was written by basic neuroscience groups from three different departments of the Institute of Biomedical Sciences at USP. Based on their use of several methodologies including morphology, pharmacology, physiology and neurochemical techniques, they describe their interdisciplinary efforts using animal models to investigate pathophysiological aspects of Alzheimer's disease and Parkinson's disease, contrasting their results with recent potential therapeutic targets and mechanisms of neuroprotection that may be evaluated in future clinical studies.
together neuroscientists from different specialties to investigate, in large and representative clinical samples, issues that are important to day-to-day clinical practice as well as to the elucidation of ethiopathogenic processes involved in neuropsychiatric disorders. The paper by Martinho et al.
from different laboratories of the Medical School of USP in try, epidemiology, neuropsychology and molecular biology; they were brought together to investigate the relationship of gene variants related to neuroplasticity with the clinical investigated using neuroimaging tecniques. 3 This collaboration underscores our current trend towards organizing data repositories containing information from multiple types of biomarkers collected in the same, representative cohorts of traditional model of conducting smaller-scale case-control studies, with one single methodological approach being applied in each sample. Finally, in the article by Kandratavicius et al., neurologists from the Medical School of Ribeirão Preto, who have recent experience in conducting multicentric studies on epilepsy, 4 have worked in collaboration with psychiatrists from the same medical school of USP to review a theme of great importance for both specialties: the comorbidity between mood disorders and epilepsies.
We believe that this volume highlights the ways in which the teams of NAPNA-USP aim to contribute to the advancement of neuroscience in Brazil over the next few years, and of RBP Psychiatry.
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O avanço da neurociência aplicada aos transtornos psiquiátricos e neurológicos: mais do que nunca, uma tarefa interdisciplinar
Apesar dos enormes avanços das pesquisas em neurociência de esclarecer a etiopatogenia dos transtornos psiquiátricos e neurológicos e de desenvolver tratamentos verdadeiramente capazes de interferir com os processos patológicos locais no mundo têm investido no fortalecimento de colaborações interdisciplinares, somando os potenciais de laboratórios bem estabelecidos nas suas respectivas áreas de atuação em neurociência. 1, 2 Tais colaborações facilitam a feitura de estudos longitudinais multicêntricos com coletas seriadas de múltiplos biomarcadores em portadores de transtornos neuropsiquiátricos. Adicionalmente, o emprego de modelos animais e outros métodos da neurociência básica permite nos neuropsiquiátricos e à resposta clínica dos pacientes aos tratamentos atuais. Assim, a integração das pesquisas clínicas de novos alvos terapêuticos e novos agentes farmacológicos para o tratamento de transtornos neuropsiquiátricos.
Em 2011, a Pró-Reitoria de Pesquisa (PRP) da Universidade de São Paulo (USP) selecionou propostas para a criação de novos Núcleos de Apoio à Pesquisa, destinados a integrar especialistas de uma ou mais faculdades e/ou institutos em torno de programas de pesquisa interdisciplinares. acima, um grupo de mais de 40 acadêmicos com linhas de à Pesquisa em Neurociência Aplicada (NAPNA-USP). Esse grupo, do qual fazem parte psiquiatras, neurologistas, radiologistas, cientistas das áreas básicas, farmacologistas, epidemiologistas, psicólogos, engenheiros e cientistas da pesquisas translacionais que abordassem um número amplo de transtornos neuropsiquiátricos. Para conseguir isso, nós os tipos de equipamentos e a todos os recursos humanos disponíveis em cada um dos grupos de pesquisa da USP. O ção e processamento dos dados clínicos e biológicos entre grande repositório de dados para uso compartilhado. Será priorizado o estudo de marcadores biológicos úteis para o estabelecimento de diagnósticos neuropsiquiátricos e para a previsão de desfechos na prática clínica, de modo interdisciplinar. De forma articulada com tais pesquisas clínicas, serão feitos estudos com o uso de culturas neuronais e modelos animais in vivo, tanto para validar os marcadores biológicos correlatos aos que estarão sendo usados em humanos como para testes pré-clínicos de novas intervenções farmacológicas para tratamento neuropsiquiátrico.
Durante mais de um ano, as equipes do NAPNA-USP vêm se mantendo em contato cada vez mais próximo, articulando uma espécie de instituto virtual de neurociências (www.napnausp.org.br), fazendo reuniões presenciais com periodicidade semestral e dando início a diversas linhas de pesquisa interdisciplinares. Algumas dessas linhas são exempedido da RBP.
A revisão da literatura por Benadiba et al. foi escrita por pesquisadores de neurociência básica, medicina nuclear e psiquiatria da USP. O texto aborda novas aplicações de neuroimagem funcional baseadas em métodos de PET e SPECT e ilustra o quanto essas técnicas consagradas de investigação diagnóstica estão se renovando com base em achados de pesquisas translacionais de ciências básicas. Quase a totalidade dos novos radiofármacos abordados neste artigo foi desenvolvida para mapear mecanismos moleculares cerebrais desvendados recentemente, a partir de achados de pesquisas bertas de mecanismos moleculares são, agora, reconhecidas e da Doença de Parkinson.
O mesmo raciocínio se aplica à meta-análise apresentada por Maia-de-Oliveira et al. Os avanços nos conhecimentos a processos de neurotransmissão sináptica, gerados a partir das ciências básicas, têm levado a uma revisão de conceitos psiquiátricos e a propostas de modelos neuroquímicos mais complexos do que aqueles que, tradicionalmente, pressupõem de forma simplista que alterações de neurotransmissão gência de sintomas mentais. Essa meta-análise salienta as limitações das teorias que valorizam as alterações de trans- dores de diferentes laboratórios da Faculdade de Medicina da USP em São Paulo, respectivamente das áreas de psiquiatria clínica, epidemiologia, neuropsicologia e biologia molecular, para investigar a relação de variantes gênicas relacionadas à neuroplasticidade com características clínicas e cognitivas em uma amostra populacional de pacientes de primeiro episódio psicótico, os quais haviam sido investigados anteriormente com métodos de neuroimagem. 3 Essa colaboração sublinha a nossa tendência atual em direção à organização de bancos de dados que contenham informações sobre múltiplos tipos de biomarcadores coletados em coortes representativas de portadores de transtornos neuropsiquiátricos, em contraste com o modelo tradicional abordagem neurobiológica aplicada a cada amostra. Por et al., neurologistas da Faculdade de Medicina de Ribeirão Preto que acumulam experiência recente na condução de estudos multicêntricos em epilepsia 4 trabalharam em colaboração com psiquiatras da mesma unidade da USP para revisar um tema de interface humor e epilepsias.
Acreditamos que este fascículo sinaliza as contribuições to da neurociência brasileira nos próximos anos e esperamos Geraldo Busatto Filho, PhD 1 Luiz Roberto Giorgetti de Britto, PhD 2 João Pereira Leite, PhD 3
